Galeterone in men with CRPC: Results in four distinct patient populations from the ARMOR2 study

Category Primary study
JournalJournal of Clinical Oncology
Year 2014
This article has no abstract
Epistemonikos ID: ba7296ba179d9e567f726abc4bd149c6c1d33806
First added on: Feb 06, 2025